Aside
from tumor recurrence, he could also be dealing with organ rejection or a possible hormone imbalance if the tumor is active.
Not exact matches
After adjusting for age,
tumor location, and stage, researchers
from Cleveland Clinic's Dermatology & Plastic Surgery Institute discovered that women diagnosed with malignant melanoma during their pregnancy or within one year of giving birth were 5.1 - times as likely to die, 6.9 - times as likely to experience metastasis, and 9.2 - times more likely to have a
recurrence.
According to follow - up reports, Zola remained well for eight more years before dying
from a
recurrence of the
tumor in his native Italy.
ON THE ROAD Breast cancer cells may break away
from the main
tumor in clumps, already bearing most of the mutations that will drive cancer
recurrence, a study suggests.
A study
from investigators at the Massachusetts General Hospital (MGH) Cancer Center has, for the first time, identified genomic differences between the breast
tumors of African American and white women, differences that could contribute to the recognized differences in
recurrence rate and survival.
tumors from neural stem cells also contained more glioblastoma stem cells, cells that are believed to give rise to
tumor recurrence after therapy,» says Lene Uhrbom, senior lecturer at the Department of Immunology, Genetics and Pathology and lead author of the study.
Consequently, most patients with advanced disease have died
from a local
recurrence of their
tumor, even after aggressive treatment.
Researchers continue to find novel ways to explore these biomarkers using ddPCR technology, whether they are epigenetic markers to determine cancer
recurrence after surgery or cell - free DNA (cfDNA) derived
from a
tumor that reveals the effectiveness of immunotherapy.
Positron emission tomography (PET) imaging of metabolic
tumor burden at diagnosis and after induction therapy can help identify patients most at risk of follicular lymphoma (FL)
recurrence, but more work is needed to differentiate high - risk and moderate - risk patients, suggested findings
from a pooled analysis of data
from three prospective clinical trials, published in Blood.